Department of Bioengineering, Stanford University, Stanford, CA, 94305, USA.
Cancer Biology Program, Stanford University, Stanford, CA, 94305, USA.
Nat Commun. 2017 Dec 20;8(1):2212. doi: 10.1038/s41467-017-02075-1.
G-protein-coupled receptors (GPCRs) are the largest and most diverse group of membrane receptors in eukaryotes and detect a wide array of cues in the human body. Here we describe a molecular device that couples CRISPR-dCas9 genome regulation to diverse natural and synthetic extracellular signals via GPCRs. We generate alternative architectures for fusing CRISPR to GPCRs utilizing the previously reported design, Tango, and our design, ChaCha. Mathematical modeling suggests that for the CRISPR ChaCha design, multiple dCas9 molecules can be released across the lifetime of a GPCR. The CRISPR ChaCha is dose-dependent, reversible, and can activate multiple endogenous genes simultaneously in response to extracellular ligands. We adopt the design to diverse GPCRs that sense a broad spectrum of ligands, including synthetic compounds, chemokines, mitogens, fatty acids, and hormones. This toolkit of CRISPR-coupled GPCRs provides a modular platform for rewiring diverse ligand sensing to targeted genome regulation for engineering cellular functions.
G 蛋白偶联受体(GPCRs)是真核生物中最大和最多样化的膜受体家族,能够检测人体中广泛的信号。在这里,我们描述了一种分子装置,该装置通过 GPCR 将 CRISPR-dCas9 基因组调控与各种天然和合成的细胞外信号偶联。我们利用先前报道的设计 Tango 和我们的设计 ChaCha 为融合 CRISPR 到 GPCR 生成了替代架构。数学模型表明,对于 CRISPR ChaCha 设计,多个 dCas9 分子可以在 GPCR 的整个生命周期中释放。CRISPR ChaCha 是剂量依赖性的、可逆的,可以响应细胞外配体同时激活多个内源性基因。我们将该设计应用于多种感知广泛配体的 GPCR,包括合成化合物、趋化因子、有丝分裂原、脂肪酸和激素。这个 CRISPR 偶联 GPCR 的工具包为重新布线各种配体感应到靶向基因组调控提供了一个模块化平台,用于工程细胞功能。